Pfizer is the world’s largest research based, pharmaceutical company. Its capital structure is designed to support the organizations debt, equity and market risk premium. Currently, Pfizer Inc. has three major core business segments: pharmaceutical, consumer health and animal health. In 2003, over 1 billion prescriptions were written for Pfizer medicines (Berardi, 2006) With all of their success and market dominance, one key challenge Pfizer experiences when protecting its assets is protecting its patents. For instance, bringing drugs successfully to the market starting with the ‘beakers in the lab” to obtaining patents can be very costly. Thus, in order to ensure its success, Pfizer has a four phase process which consists of Phase 1: testing on healthy human populations; Phase 2: testing on diseased populations; Phase 3: applying drugs to a large patient population and pitted against competitors in the market and also approved
Pfizer is the world’s largest research based, pharmaceutical company. Its capital structure is designed to support the organizations debt, equity and market risk premium. Currently, Pfizer Inc. has three major core business segments: pharmaceutical, consumer health and animal health. In 2003, over 1 billion prescriptions were written for Pfizer medicines (Berardi, 2006) With all of their success and market dominance, one key challenge Pfizer experiences when protecting its assets is protecting its patents. For instance, bringing drugs successfully to the market starting with the ‘beakers in the lab” to obtaining patents can be very costly. Thus, in order to ensure its success, Pfizer has a four phase process which consists of Phase 1: testing on healthy human populations; Phase 2: testing on diseased populations; Phase 3: applying drugs to a large patient population and pitted against competitors in the market and also approved